# Illumina Radiopharmaceuticals LLC — Form D

Illumina Radiopharmaceuticals LLC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-04. The offering totals $9.0M, of which $250K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-06-04
- Form: D
- Accession: 0001778748-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.0M
- Amount sold: $250K
- Remaining: $8.8M
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2019-05-17
- Revenue range: Decline to Disclose
- SEC file number: 021-341138

## Issuer

- Name: Illumina Radiopharmaceuticals LLC
- CIK: 0001778748
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: C/O CTSW 420 LEXINGTON AVENUE, NEW YORK, NY, 10170
- Phone: 212-381-8749

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| David J Battleman | Executive Officer | New York, NY |
| Scott J Korman | Executive Officer | NEW YORK, NY |
| David J Turner | Executive Officer | Sydney, NSW, C3 |

## More

- [CIK 1778748 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1778748&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001778748-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.